Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2025

Dec 23, 2025

30870_dirs_2025-12-23_f4bacce0-8339-4d57-9eff-e295b7ff5e05.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-12-22

Reporting Person: WIERENGA WENDELL (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-12-22 Common Stock M 20000 $7.61 Acquired 52444 Direct
2025-12-22 Common Stock S 20000 $66.14 Disposed 32444 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-12-22 Non-Qualified Stock Option (Right to Buy) $7.61 M 20000 Disposed 2026-05-18 Common Stock (20000) Direct